Definitive Contract HHSN268201200036C
Award Date 1/10/12
Potential Completion Date 12/31/15
Potential Value $3.6M
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98195, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order to the University of Washington's Office of Sponsored Programs for Task Area B of the Cardiovascular Health Study (CHS) Biorepository-Based Research Projects. This cost-no-fee contract, valued at $674,371, supports biorepository-based research initiatives critical to the NHLBI's mission of advancing cardiovascular and pulmonary health through scientific investigation. The contract was originally awarded on April 1,...
- This is a definitive, firm fixed price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Washington. The contract, valued at $783,706.00, is for special studies and analysis services. The University of Washington has a history of delivering a range of services to federal agencies, including research and development work. This contract does not have a set-aside designation. The University of Washington also holds a separate $500...
- The federal contract award is for the Multi-Ethnic Study of Atherosclerosis (MESA) program, which is administered by the National Heart, Lung, and Blood Institute (NHLBI) under the Department of Health and Human Services (HHS). The contract was awarded to the University of Washington (UW), a leading research university, to provide research services. The contract has a potential value of $348,474.65 and covers the period from August 1, 2016 to December 31, 2016. The contract is a delivery order...
- The National Heart Lung and Blood Institute (NHLBI) awarded a delivery order to the University of Washington's Office of Sponsored Programs for continued core study operations supporting the Cardiovascular Health Study (CHS). This modification extends the period of performance through January 15, 2025 at no additional cost to the government. The contract operates under a cost no-fee structure with a ceiling value of $6.89M and was originally awarded on November 1, 2020. The work will be...
- This federal contract award to the University of Washington (UW) was issued by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), for RNA sequencing laboratory services. The $429,539.93 firm-fixed-price contract has an ultimate completion date of October 17, 2020. UW will provide the required RNA sequencing and data analysis services on biological samples to further NHLBI's scientific research. This award is not associated with a...
- This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the University of Washington. The contract is for $116,617.00 and has an ultimate completion date of September 29, 2017. The award is for a non-R&D project titled "IDENTIFYING COMMENSURATION BIAS IN NIH/CSR PEER REVIEW" and does not have a set-aside designation. The University of Washington is a leading...
- This is a firm-fixed price delivery order under the "MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)III- COORDINATING CENTER" contract, awarded by the National Heart Lung and Blood Institute (NHLBI) to the University of Washington. The $19,824,860.60 award has an ultimate completion date of August 14, 2019 and covers research coordination services for the MESA study, a large-scale cardiovascular disease research initiative. There is no set-aside designation for this contract. The...
- The University of Washington was awarded a firm fixed-price purchase order in the amount of thirteen thousand one hundred sixty-nine dollars and twenty-six cents ($13,169.26) by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for platelet RNA sequencing services in support of the Framingham Heart Study, with no set-aside designation. Performance will take place in Bethesda, Maryland through September 2020. No...
- This federal contract award to the University of Washington (UW) is a $150,000 grant for the execution of a balanced science program based on guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and direction from Congress. The contract has an ultimate completion date of November 15, 2028. UW is a prominent public research university that frequently competes for and wins unrestricted federal contracts and grants across various scientific...
- This is a $26,116,402.00 definitive cost no fee contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the University of Washington (UW). The contract is for biomedical (applied/exploratory) services. It does not have a set-aside designation. UW is a leading public research university that leverages its academic and research capabilities to support various federal agencies through contracts and grants. The university often serves...